Non Regulatory-Interview with Dennis Purcell
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SVNS notes
Graft Polymer (UK) PLC (LON: GPL), an innovative biotechnology company focused on co-developing therapeutics for mental health disorders, is pleased to note an interview on Proactive Investors with the Company's new Chairman, Dennis Purcell. Mr Purcell's appointment was announced earlier today.
The interview and accompanying article can be viewed at Proactive Investors: Graft Polymer UK appoints biotechnology industry leader Dennis Purcell as Chairman.
For more information, please visit www.graftpolymer.co.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.